Myomo, Inc.
AMEX:MYOMedical - Devices
-$0.13 today
- Market cap
- $50.12M
- Beta
- 1.46
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$0.36
Volume 0.21M
Average 0.62M
MYO Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Myomo, Inc.AMEX: MYO
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables grows, but more slowly than its trailing trend
Q1 FY2026 accounts receivables of $691.04K (cash outflow) rose 8.5% year over year, behind the +111.1% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +99.5% a year.
Context
- Accounts receivables amounted to 0.9% of revenue in FY2025, down 3.9 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +8.5% toward the trailing-twelve-month pace of +111.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 376.97K USD
- Year-over-year change
- +124.2%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 376.97K | +124.2% |
| FY2024 | 2024-12-31 | (1.56M) | -214.7% |
| FY2023 | 2023-12-31 | (495.6K) | -1144.6% |
| FY2022 | 2022-12-31 | 47.45K | +104.5% |
| FY2021 | 2021-12-31 | (1.05M) | — |
Accounts Receivables vs competitors
How MYO compares with its peers on the latest reported figures
- MYO's LTM Mar 2026 accounts receivables of $322.98K is the 2nd largest of the 4 companies compared; the peer median is $0.
- Its year-over-year change of +111.1% is the highest of 4, against a peer median of -100.0%.
- Accounts receivables amounts to 0.8% of revenue for MYO, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $3.15M | -494.7% | +94.1% | 10.9% | |
| LTM Mar 2026 | $322.98K | +111.1% | +99.5% | 0.8% | |
| LTM Mar 2026 | $78K | +107.6% | — | 0.2% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding MYO) | $0 | -100.0% | +94.1% | 0.2% | |
Competitors are the stored peer set for MYO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (10.37M) | (10.72M) | (8.15M) | (6.18M) | (15.57M) |
| Depreciation & Amortization | 335.96K | 542.63K | 517.68K | 776.97K | 1.98M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.1M | 1.19M | 1.12M | 874.44K | 2.08M |
| Change in Working Capital | (588.01K) | (1.45M) | 293.21K | 1.26M | (3.86M) |
| Accounts Receivables | (1.05M) | 47.45K | (495.6K) | (1.56M) | 376.97K |
| Inventory | (118.22K) | (607.4K) | (384.78K) | (1.4M) | (662.68K) |
| Accounts Payables | 1.11M | (711.9K) | 1.79M | 4.69M | (2.9M) |
| Other Working Capital | 576.49K | (178.13K) | (616.54K) | (478.7K) | (668.57K) |
| Other Non-Cash Items | (19.73K) | 204.34K | 48.31K | (17.37K) | 855.86K |
| Operating Cash Flow | (9.55M) | (10.23M) | (6.17M) | (3.29M) | (14.51M) |
| Capital Expenditures | (326.46K) | (111.79K) | (145.82K) | (1.36M) | (1.74M) |
| Acquisitions (Net) | 0 | (199K) | 0 | 0 | 0 |
| Purchases of Investments | 0 | (199K) | (5.88M) | (5.98M) | (5.47M) |
| Sales of Investments | 0 | 398K | 4M | 7.6M | 1.74M |
| Other Investing Activities | 0 | (199K) | 0 | 0 | (1.59M) |
| Investing Cash Flow | (326.46K) | (310.79K) | (2.03M) | 259.98K | (7.06M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 11.43M |
| Common Stock Issued | 1.1M | 376.86K | 9.72M | 20.37M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 12.07M | 0 | (8.12K) | 563.64K | 0 |
| Financing Cash Flow | 13.17M | 376.86K | 9.71M | 20.93M | 11.43M |
| Effect of Forex Changes | (10.39K) | (10.93K) | 14.21K | (26.44K) | 101.7K |
| Net Change in Cash | 3.28M | (10.18M) | 1.53M | 17.88M | (10.04M) |
| Free Cash Flow | (9.87M) | (10.35M) | (6.32M) | (4.65M) | (16.25M) |
Myomo, Inc.
AMEX:MYO
Intrinsic Alpha fair value
Locked
Current Price
$1.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.